Thousands of people throughout the UK are dealing with a enigmatic and incapacitating skin disorder that has left the medical profession baffled. Sufferers describe their skin as becoming intensely inflamed with cracking and peeling, commonly affecting large areas of their body, yet many doctors have trouble diagnosing or treating the condition. The condition, referred to as topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social platforms, with clips featuring patients’ experiences receiving more than a billion views on TikTok alone. Although it affects a rising number of people, TSW is so little understood that some general practitioners and dermatologists doubt whether it exists at all. Now, for the first time, researchers across the UK are commencing a significant research project to examine what is behind these mysterious symptoms and why some people develop the condition whereas others do not.
The Puzzling Condition Spreading Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had controlled her eczema successfully with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became severely inflamed and reddened, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so acute that she was unable to leave her bed, dependent on continuous support from her mother. Most concerning, Bethany was repeatedly dismissed by doctors who ascribed her symptoms to standard eczema and persistently prescribed the very treatments she suspected were triggering her suffering.
The healthcare sector remains divided on how to manage TSW, with fundamental disagreement about its core nature. Some experts view it as a severe allergic response to the steroid creams that represent the standard treatment for eczema across the NHS. Others argue it represents a severe flare-up of existing skin conditions rather than a distinct syndrome, whilst a minority are sceptical of its reality. This professional uncertainty has left patients like Bethany stuck in a diagnostic uncertainty, finding it hard to obtain suitable treatment. The failure to reach consensus has led Professor Sara Brown at the Edinburgh University to set up the inaugural major UK research project studying TSW, supported by the National Eczema Society.
- Symptoms involve significant swelling, cracking skin and persistent pruritus throughout the body
- Patients report “elephant skin” thickening and extreme shedding of keratinised cells
- Healthcare practitioners often dismiss TSW as typical dermatitis or decline to recognise it
- The condition can be so debilitating that sufferers find themselves unable to perform daily activities
Living with Topical Steroid Withdrawal
From Controllable Eczema to Debilitating Symptoms
For numerous sufferers, withdrawal from topical steroids represents a catastrophic deterioration from a formerly stable dermatological condition. What begins as occasional itching in skin creases can quickly progress into a full-body inflammatory response that renders patients unable to function. The transition often occurs abruptly, without warning, transforming a manageable chronic condition into an acute medical crisis. Patients report their skin becoming intensely hot, inflamed and red, with severe cracking and weeping that requires constant attention. The bodily burden is compounded by exhaustion, as the relentless itching prevents sleep and recovery, creating a destructive cycle of decline.
The rate at which TSW progresses takes many sufferers by surprise. Those who have experienced eczema for years, sometimes decades, are unprepared for the intensity of symptoms that appear when their condition suddenly worsens. Routine activities become formidable obstacles: showering becomes unbearable, dressing demands help, and maintaining personal hygiene demands substantial energy. Some patients describe feeling as though their skin is under assault from within, with inflammation moving through their body in patterns that differ markedly to their previous eczema flare-ups. This dramatic transformation often prompts sufferers to pursue immediate medical attention, only to face doubt from healthcare professionals.
The Push for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the dismissive medical responses that commonly occurs with it. Patients experiencing serious, unexplained health issues are routinely told they simply have eczema flaring up, despite their insistence that this is essentially distinct from anything they’ve experienced before. Doctors frequently react by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers experiencing abandonment by the medical establishment, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their worries disregarded as emotional or psychological in nature rather than actual physical health issues.
The lack of professional agreement has created a significant divide between what patients report and clinical acknowledgement. Without clear diagnostic criteria or established treatment protocols, general practitioners and skin specialists find it difficult to diagnose TSW or offer appropriate support. Some practitioners remain completely sceptical the disorder is real, viewing all acute cases as standard eczema or recognised skin disorders. This clinical doubt results in delayed diagnosis, unsuitable therapies and profound psychological distress for people experiencing physical symptoms. The increased prominence of TSW on online platforms has drawn attention to this diagnostic gap, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the healthcare profession continues to disagree on how to respond.
- Symptoms can emerge abruptly in individuals with formerly controlled eczema managed by steroid creams
- Patients frequently encounter disbelief from healthcare professionals who attribute worsening to standard eczema flares
- Medical professionals remain divided on whether TSW is a real disorder or acute eczema flare-up
- Lack of diagnostic criteria means many sufferers struggle to access appropriate treatment and assistance
- Online platforms has magnified voices of patients, with TSW hashtags accumulating more than one billion views worldwide
Racial Inequities in Diagnostic and Treatment Pathways
The diagnostic difficulties surrounding TSW become increasingly evident amongst those with darker complexions, where symptoms can be significantly harder to identify visually. Redness and inflammation, the hallmark signs of TSW in people with lighter skin, manifest differently across various ethnicities, yet many assessment protocols remain focused on how the condition appears in white patients. This disparity means that Black, Asian and other people of colour experiencing TSW often face substantially longer periods in identification and acceptance. Healthcare professionals trained primarily on manifestations in lighter-skinned individuals may fail to recognise the typical indicators, leading to further misdiagnosis and unsuitable therapeutic suggestions that can worsen symptoms.
Research into TSW has historically overlooked the lived experiences with darker complexions, perpetuating a cycle where their condition goes under-documented and under-studied. The online discussions dominating TSW discussions have been largely shaped by individuals with lighter complexions, potentially skewing clinical knowledge and community understanding. As Professor Sara Brown’s groundbreaking UK study advances, guaranteeing inclusive participation amongst research participants will be essential to creating genuinely comprehensive diagnostic criteria and treatment approaches. Without intentional action to prioritise the perspectives of diverse populations, healthcare disparities in TSW recognition and management risk widening further, abandoning at-risk communities without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Solutions Emerging
First Major UK Research Project Currently Happening
Professor Sara Brown’s pioneering research at the University of Edinburgh represents a turning point for TSW sufferers pursuing validation and understanding. Funded by the National Eczema Society, the study has recruited many participants in the UK to investigate the underlying mechanisms driving topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers seek to identify why particular individuals exhibit TSW whilst others using identical steroid regimens do not. This detailed analysis marks a notable change from dismissal to serious investigation.
The study team partnering with Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and lived experience to the investigation. Their partnership approach acknowledges that patients themselves hold vital knowledge into their conditions. Professor Brown has identified patterns in TSW that cannot be explained by conventional eczema understanding, including distinctive “elephant skin” thickening, extreme shedding and clearly defined inflammatory patches. The study’s findings could fundamentally reshape how medical professionals manage diagnosis and treatment of this debilitating condition.
Available Treatments and Associated Limitations
Currently, therapeutic approaches to TSW remain limited and often unsatisfactory. Many medical practitioners continue prescribing topical steroids despite evidence indicating they could worsen symptoms in susceptible individuals. Some patients report temporary relief from moisturisers, antihistamines and systemic drugs, though results vary widely. Dermatologists continue to disagree on best treatment approaches, with some supporting total steroid discontinuation whilst others advocate phased withdrawal. This lack of consensus sees patients managing their treatment journeys mostly in isolation, drawing substantially on peer support networks and digital communities for direction.
Psychological assistance with specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including dietary modifications, managing environmental factors and whole-person treatment approaches, though scientific evidence validating such approaches is limited. The absence of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollients and moisturisers to maintain skin barrier function and reduce water loss
- Antihistamines to control itching and associated sleep disruption in flare episodes
- Systemic corticosteroids or immune-suppressing agents for serious presentations with specialist oversight
- Mental health support to address trauma and anxiety related to chronic skin conditions
Voices of Hope and Determination
Despite the lack of clarity surrounding TSW and the frequently dismissive attitudes from medical practitioners, patients are finding strength in shared community and collective experience. Digital support communities have emerged as lifelines for those struggling with the disorder, offering practical guidance and validation when conventional medicine has let them down. Many individuals affected recount the point at which they found the TSW hashtag as pivotal—finally connecting with others with the same symptoms and realising they were not alone in their suffering. This unified voice has proven powerful enough to trigger the first serious research efforts, showing that patient-led campaigns can advance medical understanding even when institutional structures stay unconvinced.
Bethany Gamble and those facing comparable challenges are determined to raise awareness and advocate for appropriate acknowledgement of TSW within the healthcare sector. Their openness in discuss intimate experiences of their challenges on social media has encouraged open dialogue around a condition that various medical professionals still are unwilling to accept. These individuals are not remaining passive for solutions; they are taking part in research studies, recording their manifestations thoroughly, and requiring that their testimonies be treated with respect. Their determination in the confronting persistent distress and invalidating medical treatment provides encouragement that responses might prove to be within attainment, and that those to come will receive the acknowledgement and treatment they urgently require.
- Patient-led research initiatives are addressing shortcomings overlooked by conventional healthcare systems and advancing knowledge of TSW
- Digital support networks offer psychological assistance, actionable management techniques, and mutual recognition for isolated sufferers worldwide
- Advocacy efforts are incrementally changing clinical attitudes, encouraging dermatologists to investigate rather than dismiss individual accounts
